Clinical Trial Update: Tryptophan-Kynurenine Pathway Metabolism in the Pathophysiology of Cognitive Impairment in Schizophrenia.

View source ↗

Summary

A clinical trial investigating the role of tryptophan-kynurenine pathway metabolism in cognitive impairment associated with schizophrenia, currently enrolling b…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia

Snippet

Sponsor: Tianjin Anding Hospital | Conditions: Schizophrenia | Status: ENROLLING_BY_INVITATION